Journal
JOURNAL OF EXPERIMENTAL MEDICINE
Volume 215, Issue 10, Pages 2477-2479Publisher
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20181617
Keywords
-
Categories
Funding
- Roche Ventana
Ask authors/readers for more resources
Chris Boshoff, Senior Vice President of Immuno-Oncology, Translational and Early Development at Pfizer, and colleagues Samra Turajlic and Charles Swanton from the Francis Crick Institute and University College London give us their personal point of view on new insights and future therapeutic approaches for renal cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
